Vaughan Nelson Investment Management, L.P. Astrazeneca PLC Transaction History
Vaughan Nelson Investment Management, L.P.
- $10.6 Billion
- Q3 2025
A detailed history of Vaughan Nelson Investment Management, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Vaughan Nelson Investment Management, L.P. holds 23,726 shares of AZN stock, worth $1.97 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,726Holding current value
$1.97 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,442Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.32 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.43 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.86 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.61 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.59 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $258B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...